Modeling Across Scales Identifies a TFRC-Influenced Immunosuppressive Macrophage Environment in Cervical Cancer
-
By
-
Yusha Chen
-
Ling Wang
-
Suyu Li
-
Jimiao Huang
-
Leilei Zhu
-
Xiqi Huang
-
Xiangqin Zheng
-
Diling Pan
-
Chuanzhong Huang
-
July 17, 2026
Clinical Scorecard: Modeling Across Scales Identifies a TFRC-Influenced Immunosuppressive Macrophage Environment in Cervical Cancer
At a Glance
| Category | Detail |
|---|
| Condition | Cervical Cancer |
| Key Mechanisms | Tumor-associated macrophages (TAMs) exhibit plasticity influencing the immunosuppressive microenvironment. |
| Target Population | Patients with cervical cancer, particularly those with advanced or recurrent disease. |
| Care Setting | Oncology and cancer research. |
Key Highlights
- Development of a five-gene prognostic signature (TP73, TFRC, SHC1, SCD, PFKFB3) for cervical cancer.
- High risk scores correlate with suppressed antitumor immune landscape and reduced chemosensitivity.
- TFRC identified as a key factor in promoting M2-like macrophage polarization and immune evasion.
Guideline-Based Recommendations
Diagnosis
- Utilize transcriptomic data for prognostic stratification in cervical cancer.
Management
- Consider targeting TFRC and macrophage polarization in therapeutic strategies.
Monitoring & Follow-up
- Assess immune landscape changes in response to treatment.
Risks
- Inferior survival and therapeutic resistance associated with M2-like polarization.
Patient & Prescribing Data
Cervical cancer patients with varying clinicopathological features.
High TFRC levels may indicate poor prognosis and reduced response to cisplatin.
Clinical Best Practices
- Integrate macrophage plasticity into prognostic models for cervical cancer.
- Validate findings through multi-scale experimental approaches.
Related Resources & Content
